Search research articles
Contact Us
Filters
Showing results (581-590 of 599) with videos related to
Page
of 60
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
The Lancet. Infectious Diseases
|
February 19, 2021
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
Martin Hoenigl, Jon Salmanton-García, Thomas J Walsh, et al.
JAMA Neurology
|
November 10, 2025
Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trial
David S Knopman, Deborah Koltai, Daniel T Laskowitz, et al.
Journal of the American Geriatrics Society
|
September 1, 2025
Age-Related Changes in the Clinical Picture of Long COVID
Mindy J Fain, Benjamin D Horne, Leora I Horwitz, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2022
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, et al.
JAMA
|
July 10, 2023
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial
Jane A O'Halloran, Emily R Ko, Kevin J Anstrom, et al.
The Lancet. Infectious Diseases
|
June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study
Johan A Maertens, George R Thompson, Andrej Spec, et al.
JAMA
|
December 18, 2024
2024 Update of the RECOVER-Adult Long COVID Research Index
Linda N Geng, Kristine M Erlandson, Mady Hornig, et al.
Nature Communications
|
November 17, 2025
Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort
Tanayott Thaweethai, Sarah E Donohue, Jeffrey N Martin, et al.
JAMA Network Open
|
September 25, 2025
Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort
Leora I Horwitz, Jacqueline H Becker, Weixing Huang, et al.
Page
of 60
Search research articles
Search
Showing results (581-590 of 599) with videos related to
Sort By:
Page
of 60
Medrxiv : the Preprint Server for Health Sciences
|
September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
The Lancet. Infectious Diseases
|
February 19, 2021
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
Martin Hoenigl, Jon Salmanton-García, Thomas J Walsh, et al.
JAMA Neurology
|
November 10, 2025
Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trial
David S Knopman, Deborah Koltai, Daniel T Laskowitz, et al.
Journal of the American Geriatrics Society
|
September 1, 2025
Age-Related Changes in the Clinical Picture of Long COVID
Mindy J Fain, Benjamin D Horne, Leora I Horwitz, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2022
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, et al.
JAMA
|
July 10, 2023
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial
Jane A O'Halloran, Emily R Ko, Kevin J Anstrom, et al.
The Lancet. Infectious Diseases
|
June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study
Johan A Maertens, George R Thompson, Andrej Spec, et al.
JAMA
|
December 18, 2024
2024 Update of the RECOVER-Adult Long COVID Research Index
Linda N Geng, Kristine M Erlandson, Mady Hornig, et al.
Nature Communications
|
November 17, 2025
Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort
Tanayott Thaweethai, Sarah E Donohue, Jeffrey N Martin, et al.
JAMA Network Open
|
September 25, 2025
Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort
Leora I Horwitz, Jacqueline H Becker, Weixing Huang, et al.
Page
of 60